Enorama Pharma AB
Research Enorama Pharma AB (ERMA) on Bullrun: market cap SEK 19.02M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerERMA
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencySEK
- Market capSEK 19.02M
- Financial periodQ4 2025
- RevenueSEK 1.75M
- Net income-SEK 20.57M
- Free cash flow-SEK 14.79M
- Gross margin-201.9%
Valuation Snapshot
latest market cap is SEK 19.02M.
About Enorama Pharma AB
Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum in Sweden. It offers nicotine chewing gum and nicotine pouches under the NIC-S brand name. The company was incorporated in 2006 and is based in Malmö, Sweden.
Frequently asked questions
What is Enorama Pharma AB's market cap?
Enorama Pharma AB's market capitalization is SEK 19.02M.
What does Enorama Pharma AB do?
Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum in Sweden. It offers nicotine chewing gum and nicotine pouches under the NIC-S brand name. The company was incorporated in 2006 and is based in Malmö, Sweden.